At a glance
- Originator Purdue Pharma
- Class Neuroprotectants; Nootropics
- Mechanism of Action Glutamate receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Stroke
Most Recent Events
- 21 Jul 1999 Discontinued-Preclinical for Stroke in USA (Unknown route)
- 20 Feb 1997 New profile
- 20 Feb 1997 Preclinical development for Stroke in USA (Unknown route)